Table 1.
Characteristics | No. (%) |
---|---|
Age at baseline, years | |
Median | 63 |
range | 34-83 |
Sex | |
Male | 15 (37.5) |
Female | 25 (62.5) |
M stage at diagnosis | |
M0 | 3 (7.5) |
M1a | 6 (15) |
M1b | 31 (77.5) |
EGFR mutation | |
19del | 19 (47.5) |
L858R | 16 (40) |
Others | 5 (12.5) |
EGFR-TKI received | |
Gefitinib | 2 (5) |
Erlotinib | 9 (22.5) |
Afatinib | 29 (72.5) |